Gastroenterology Education and CME

My Education
Keep track of all your educational activities here
  • Access activities already in progress
  • See credits earned to date
  • Print certificates
  • Top Picks
    • The JAK-STAT Pathway in Inflammatory Bowel Disease: Expert Insights and Discussion of the Latest Research
    • Familial Chylomicronemia Syndrome: Cause, Effect, and Solutions to Improve Patients' Quality-of-Life
    • What’s Hot in GI, What’s Not?
    • Emerging Agents: A Deeper Look

Select a Topic

  • FILTER BY:
The JAK-STAT Pathway in Inflammatory Bowel Disease - Expert Insights and Discussion of the Latest Research
CME

The JAK-STAT Pathway in Inflammatory Bowel Disease: Expert Insights and Discussion of the Latest Research

This activity is supported by an independent educational grant from Pfizer.

Expiration Date: 12/28/2017
Credit Type(s): CME | Credit: 1

Russell D. Cohen, MD, and Thomas A. Ullman, MD, summarize clinical data on JAK inhibitors in inflammatory bowel disease (IBD). In addition to discussing the rationale…

go to activity»
What You Need to Know About Familial Chylomicronemia Syndrome: Pathophysiology, Diagnosis, Management, and the Patient Perspective
CMECNECPE

What You Need to Know About Familial Chylomicronemia Syndrome: Pathophysiology, Diagnosis, Management, and the Patient Perspective

This activity is supported by an educational grant from Akcea Therapeutics™ A Subsidiary of Ionis Pharmaceuticals, Inc.
Endorsed by: The National Lipid Association.

Expiration Date: 5/15/2018
Credit Type(s): CNE / CME / CPE | Credit: 1

Familial chylomicronemia syndrome (FCS) is a rare genetic disease that leads to severe hypertriglyceridemia and recurrent episodes of acute pancreatitis. Due to its…

go to activity»
Clostridium difficile: Not Just a Hospital Infection
CME

Clostridium difficile: Not Just a Hospital Infection

This activity is supported by an educational grant from Merck & Co., Inc.

Expiration Date: 10/1/2017
Credit Type(s): CME | Credit: 1.25

There has been an increase in the number of infections caused by various strains of Clostridium difficile (C. difficile). Key factors in the management of the disease…

go to activity»
Loss of response
CMEVIDEO

Loss of Response in the Treatment of Crohns Disease: A Case Study

This activity is supported by an educational grant from Receptos.

Expiration Date: 9/22/2017
Credit Type(s): CME | Credit: 0.25

Anti-TNF agents are effective for inducing and maintaining remission in patients with Crohn's disease. However, a significant number of patients who initially respond to…

go to activity»
Cover
CME

Emerging Agents: A Deeper Look

This activity is supported by an educational grant from Receptos.

Expiration Date: 9/22/2017
Credit Type(s): CME | Credit: 0.25

There are quite a few agents in development for the treatment of ulcerative colitis and Crohn's disease, and many of these have novel mechanisms of action. As Dr. Bruce…

go to activity»
j195
CME

When to Switch and When to Stop

Expiration Date: 9/8/2017
Credit Type(s): CME | Credit: 0.25

Inflammatory bowel disease is heterogeneous, so individualizing therapy based on disease type, severity, and prognosis is crucial. In this CME program, Dr. David Rubin…

go to activity»
Familial Chylomicronemia Syndrome: Cause, Effect, and Solutions to Improve Patients' Quality-of-Life
CMECNECPE

Familial Chylomicronemia Syndrome: Cause, Effect, and Solutions to Improve Patients' Quality-of-Life

This activity is supported by an educational grant from Akcea Therapeutics™ A Subsidiary of Ionis Pharmaceuticals, Inc.
Endorsed by: The National Pancreas Foundation.

Expiration Date: 5/15/2018
Credit Type(s): CME / CNE / CPE | Credit: 1

Familial chylomicronemia syndrome (FCS) is a rare and potentially life-threatening genetic disease. The clinical hallmark of FCS is pancreatitis associated with marked…

go to activity»
cover image
CME

Age Matters: Implementing New Recommendations for HPV Immunization in Adolescents

This activity is supported by an educational grant from Merck & Co., Inc.

Expiration Date: 4/10/2018
Credit Type(s): CME | Credit: 1.5

Human papillomavirus (HPV) infection is the most common sexually transmitted infection in the United States, as well as a cause of various types of cancer. An estimated…

go to activity»
S1P Receptor Modulators
CMEVIDEO

S1P Receptor Modulators

This activity is supported by an educational grant from Receptos.

Expiration Date: 9/22/2017
Credit Type(s): CME | Credit: 0.25

Modulators of the sphingosine-1-phosphate subtype 1 (S1P1) and S1P5 receptors are being investigated in the treatment of Crohn’s disease and ulcerative colitis…

go to activity»
JAK Inhibitors
CMEVIDEO

JAK Inhibitors

This activity is supported by an educational grant from Receptos.

Expiration Date: 9/22/2017
Credit Type(s): CME | Credit: 0.25

Janus kinase (JAK) inhibitors have emerged as  novel, orally administered small molecule therapies for the treatment of inflammatory bowel disease. In this CME…

go to activity»
j195
CME

What’s Hot in GI, What’s Not?

Expiration Date: 9/8/2017
Credit Type(s): CME | Credit: 0.25

It is a time of active research in inflammatory bowel disease (IBD). In this CME activity, Dr. Gary Lichtenstein discusses the hot topics in IBD, including…

go to activity»
The JAK-STAT Pathway in Inflammatory Bowel Disease - Expert Insights and Discussion of the Latest Research
CME

The JAK-STAT Pathway in Inflammatory Bowel Disease: Expert Insights and Discussion of the Latest Research

This activity is supported by an independent educational grant from Pfizer.

Expiration Date: 12/28/2017
Credit Type(s): CME | Credit: 1

Russell D. Cohen, MD, and Thomas A. Ullman, MD, summarize clinical data on JAK inhibitors in inflammatory bowel disease (IBD). In addition to discussing the rationale…

go to activity»
Familial Chylomicronemia Syndrome: Cause, Effect, and Solutions to Improve Patients' Quality-of-Life
CMECNECPE

Familial Chylomicronemia Syndrome: Cause, Effect, and Solutions to Improve Patients' Quality-of-Life

This activity is supported by an educational grant from Akcea Therapeutics™ A Subsidiary of Ionis Pharmaceuticals, Inc.
Endorsed by: The National Pancreas Foundation.

Expiration Date: 5/15/2018
Credit Type(s): CME / CNE / CPE | Credit: 1

Familial chylomicronemia syndrome (FCS) is a rare and potentially life-threatening genetic disease. The clinical hallmark of FCS is pancreatitis associated with marked…

go to activity»
What You Need to Know About Familial Chylomicronemia Syndrome: Pathophysiology, Diagnosis, Management, and the Patient Perspective
CMECNECPE

What You Need to Know About Familial Chylomicronemia Syndrome: Pathophysiology, Diagnosis, Management, and the Patient Perspective

This activity is supported by an educational grant from Akcea Therapeutics™ A Subsidiary of Ionis Pharmaceuticals, Inc.
Endorsed by: The National Lipid Association.

Expiration Date: 5/15/2018
Credit Type(s): CNE / CME / CPE | Credit: 1

Familial chylomicronemia syndrome (FCS) is a rare genetic disease that leads to severe hypertriglyceridemia and recurrent episodes of acute pancreatitis. Due to its…

go to activity»
cover image
CME

Age Matters: Implementing New Recommendations for HPV Immunization in Adolescents

This activity is supported by an educational grant from Merck & Co., Inc.

Expiration Date: 4/10/2018
Credit Type(s): CME | Credit: 1.5

Human papillomavirus (HPV) infection is the most common sexually transmitted infection in the United States, as well as a cause of various types of cancer. An estimated…

go to activity»
Clostridium difficile: Not Just a Hospital Infection
CME

Clostridium difficile: Not Just a Hospital Infection

This activity is supported by an educational grant from Merck & Co., Inc.

Expiration Date: 10/1/2017
Credit Type(s): CME | Credit: 1.25

There has been an increase in the number of infections caused by various strains of Clostridium difficile (C. difficile). Key factors in the management of the disease…

go to activity»
S1P Receptor Modulators
CMEVIDEO

S1P Receptor Modulators

This activity is supported by an educational grant from Receptos.

Expiration Date: 9/22/2017
Credit Type(s): CME | Credit: 0.25

Modulators of the sphingosine-1-phosphate subtype 1 (S1P1) and S1P5 receptors are being investigated in the treatment of Crohn’s disease and ulcerative colitis…

go to activity»
Loss of response
CMEVIDEO

Loss of Response in the Treatment of Crohns Disease: A Case Study

This activity is supported by an educational grant from Receptos.

Expiration Date: 9/22/2017
Credit Type(s): CME | Credit: 0.25

Anti-TNF agents are effective for inducing and maintaining remission in patients with Crohn's disease. However, a significant number of patients who initially respond to…

go to activity»
JAK Inhibitors
CMEVIDEO

JAK Inhibitors

This activity is supported by an educational grant from Receptos.

Expiration Date: 9/22/2017
Credit Type(s): CME | Credit: 0.25

Janus kinase (JAK) inhibitors have emerged as  novel, orally administered small molecule therapies for the treatment of inflammatory bowel disease. In this CME…

go to activity»
Cover
CME

Emerging Agents: A Deeper Look

This activity is supported by an educational grant from Receptos.

Expiration Date: 9/22/2017
Credit Type(s): CME | Credit: 0.25

There are quite a few agents in development for the treatment of ulcerative colitis and Crohn's disease, and many of these have novel mechanisms of action. As Dr. Bruce…

go to activity»
j195
CME

What’s Hot in GI, What’s Not?

Expiration Date: 9/8/2017
Credit Type(s): CME | Credit: 0.25

It is a time of active research in inflammatory bowel disease (IBD). In this CME activity, Dr. Gary Lichtenstein discusses the hot topics in IBD, including…

go to activity»
j195
CME

When to Switch and When to Stop

Expiration Date: 9/8/2017
Credit Type(s): CME | Credit: 0.25

Inflammatory bowel disease is heterogeneous, so individualizing therapy based on disease type, severity, and prognosis is crucial. In this CME program, Dr. David Rubin…

go to activity»